Drug profile · INN
umeclidinium
INCRUSE ELLIPTA
- Patents linked
- 0
- News articles
- 0
Quick answer
umeclidinium (INCRUSE ELLIPTA) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline.
Key facts
Frequently asked questions
What is umeclidinium?
umeclidinium (INCRUSE ELLIPTA) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline.
What is the brand name for umeclidinium?
INCRUSE ELLIPTA is a marketed brand name for umeclidinium. Check FDA Drugs@FDA for the current US label holder and prescribing information.